Press release
PharmaResearch Accelerates Global Market Expansion with Investment from Global Private Equity Fund CVC
Image: https://www.getnews.info/uploads/37d3d1ec3a03e85dac6376b2c2e3bb4e.jpg
September 13th, 2024 - PharmaResearch (co-CEOs: Kang Ki Seock, Kim Thinkyou), a leader in aesthetic injectables and regenerative medicines renowned for its flagship skin booster product "Rejuran", announced a significant milestone in its global market expansion efforts, securing KRW 200 billion investment from Europe-based global private equity firm CVC through the issuance of redeemable convertible preferred shares (RCPS). Extending beyond capital injection, this investment will enable the company to accelerate overseas market entry through strategic partnership with CVC.
CVC is a leading global private equity firm that manages over 180 billion of AUM, and has a strong investment track record in the healthcare industry across Europe and other key global markets. PharmaResearch aims to leverage CVC's extensive global network and experience to achieve rapid and stable penetration into new international markets. As a strategic partner, CVC will provide valuable network and resources to support PharmaResearch's market expansion and strengthen the company's global competitiveness.
PharmaResearch plans to utilize the newly secured funds primarily for strategic overseas M&As and the establishment of local subsidiaries to implement region-specific go-to-market strategies and rapidly expand its presence in these markets. The company also intends to utilize the funds to upgrade its R&D capabilities and expand its product pipeline through acquisitions. Investments in innovative product development as well as existing product enhancements are expected to strengthen the company's product portfolio, leading to increased global competitiveness by delivering greater value to its international customers.
Kim Thinkyou, CEO of PharmaResearch, stated, "With CVC's investment and partnership, PharmaResearch is now in a stronger position to enhance its global market presence and continue focusing on developing innovative products and services. We are committed to delivering value to our customers and shareholders as we continue our journey towards becoming a global leader."
Kyoo-Cheol Chris Rhee, CVC's Head of Korea, remarked, "CVC is delighted to partner with a company like PharmaResearch." and added, "With our global network and experience, CVC is fully committed to supporting PharmaResearch's continued growth in the global market and to contributing to the growth of the K-beauty industry globally."
About PharmaResearch
PharmaResearch is a pioneering biopharmaceutical company dedicated to enhancing the quality of life for humanity through regenerative medicine. With a diverse portfolio encompassing medicines, medical devices, cosmetics, and supplements, PharmaResearch focuses on leveraging its core ingredients, DOT Registered PDRN and DOT Registered PN. These active tissue regenerative substances are powered by DOT Registered , an exclusive DNA fragments optimization technology safeguarded by a suite of patents. Headquartered in Seongnam, South Korea, PharmaResearch also operates a U.S. subsidiary, PharmaResearch USA, located in Costa Mesa, California. Key products include Rejuran Registered , Rejuviel Registered , Conjuran Registered , Rejuran Registered Cosmetics, Lian Registered Eye Drops, Rejuvenex Cream Registered , and Rejuderma Registered .
For more information about PharmaResearch and its innovative initiatives, visit http://pharmaresearch.co.kr/en/ and connect with us on LinkedIn [https://www.linkedin.com/company/pharmaresearch-corporation/].
Media Contact
Company Name: PharmaResearch USA
Contact Person: Sangjin Choi
Email: Send Email [http://www.universalpressrelease.com/?pr=pharmaresearch-accelerates-global-market-expansion-with-investment-from-global-private-equity-fund-cvc]
Country: United States
Website: http://pharmaresearch.co.kr/en
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PharmaResearch Accelerates Global Market Expansion with Investment from Global Private Equity Fund CVC here
News-ID: 3655392 • Views: …
More Releases from Getnews
Future Electronics Launches Campaign Featuring STMicroelectronics STM32 Series o …
Image: https://www.globalnewslines.com/uploads/2025/09/1757002543.jpg
Future Electronics, a leading global distributor of electronic components, has launched a new campaign showcasing the STM32 Series of Microcontrollers (MCUs) from STMicroelectronics.
Montreal, Canada - September 4, 2025 - Future Electronics, a leading global distributor of electronic components, has launched a new campaign showcasing the STM32 Series of Microcontrollers (MCUs) from STMicroelectronics.
The STM32 series of scalable 32-bit Arm Registered Cortex Registered microcontrollers delivers developers the performance and flexibility needed…
Insane Paint Auto Detailing Expands Premium Car Care Solutions in Pelham, AL
Image: https://www.globalnewslines.com/uploads/2025/09/1756993173.jpg
Insane Paint Auto Detailing has announced the expansion of its professional services to meet the growing demand for high-quality automotive and marine care in the community. The company continues to gain recognition for precision detailing, advanced protection solutions, and long-lasting results for vehicles and watercraft.
Founded on the principle of delivering exceptional care, Insane Paint Auto Detailing provides specialized treatments that go beyond traditional cleaning. The team emphasizes innovation, using…
Joya Law Firm Rebrands as Joya Injury Law to Highlight Personal Injury Focus
Joya Law Firm, P.A. has officially rebranded as Joya Injury Law, P.A., introducing a new name, logo, and website domain to align with its dedicated focus on personal injury law while maintaining its core values and services.
Image: https://www.globalnewslines.com/uploads/2025/08/c3bb2069be318d7e66664337e01a2413.jpg
Joya Law Firm, P.A., a Florida-based personal injury law practice, today announced its official rebrand to Joya Injury Law [https://joyainjurylaw.com]. The change includes a new name, refreshed logo, and updated website domain, reflecting…
Huntsville's Premier Boutique Apartment Complex, The Monarch Downtown, Announces …
The Monarch Downtown is where old-fashioned design and modern living come together, offering the perfect home for elevated lifestyles in the heart of downtown Huntsville, Alabama
Image: https://www.globalnewslines.com/uploads/2025/09/b305c492971ad06615f74e38d52de503.jpg
The Monarch Downtown [https://themonarchdowntown.com/] is officially opening its doors, bringing an exciting new option for elevated living in the heart of downtown Huntsville, Alabama. The Monarch Downtown seamlessly weaves together timeless history and modern amenities to deliver a highly sought after new apartment complex…
More Releases for PharmaResearch
Polynucleotides Injectable Overview and Leading Players: Euroresearch S, NeoGene …
The Polynucleotides Injectable market is rapidly gaining traction as a pivotal segment within the aesthetic and medical sectors. Polynucleotides, naturally occurring polymers of nucleotides, have emerged as a revolutionary ingredient in injectables, primarily due to their ability to stimulate tissue regeneration and enhance skin hydration. The relevance of this market is underscored by its applications in various therapeutic and aesthetic procedures, including skin rejuvenation, wrinkle reduction, and overall facial volumization.
𝐘𝐨𝐮…
PharmaResearch Hosts 5th Global Symposium on 'Rejuran'
Over 600 Medical Professionals from 25 Countries Participate, Launch of IRC Committee for Rejuran Global Research Team
Image: https://www.getnews.info/uploads/184db9fd8e5f5bcffadcfd0b82962264.png
Seongnam, South Korea - PharmaResearch (CEO Ki Seock Kang and Thinkyou Kim) announced today that it successfully held the 5th PharmaResearch Global Symposium (PGS) at the Lakai Sandpine Resort on October 28-29, 2024. This year's event attracted approximately 600 aesthetic and medical professionals from 25 countries across Asia, the Americas, Europe, and the…
PharmaResearch Announces 'Open Innovation Day' Running Until September 30 to Fos …
Anticipating Collaborations with Leading Companies in Aesthetic Medical Devices, Pharmaceuticals and Biotechnology: Application Period August 15 - September 30
Image: https://www.getnews.info/uploads/3276751a42ffba8429fb959e81d25795.jpg
PharmaResearch, a company specializing in regenerative medicine (CEO Kim Thinkyou, Kang Ki-seock), announced that it will host the 'Open Innovation Day'. This initiative aims to foster collaborations in innovative technologies across the aesthetic medical device, pharmaceuticals, biotechnology sectors, both domestically and internationally.
PharmaResearch is seeking partnerships in several key areas, including -…
PharmaResearch Hosts Launch Symposium for REJURAN Registered HB Plus in Singapor …
Sharing information on DOT Trademark patented technology, distinctive efficacy, and safety
Image: https://www.getnews.info/uploads/a9dbc52352e6614785a6dbafd0148817.png
PharmaResearch (CEOs Kang Ki-seok and Kim Thinkyou), a company specializing in regenerative medicine, announced earlier this month that it held a launch symposium for REJURAN Registered HB Plus at Four Seasons Hotel in Singapore.
The symposium aimed to share the technological advancements and clinical experiences of REJURAN Registered HB Plus with local aesthetic experts and medical professionals.
Dr. Michael J. Kim,…
PharmaResearch Presents 'REJURAN Registered ' as a New Solution for Flushing
Effective Use of PN for Flushing... Published in an SCIE-Level Journal
Image: https://www.getnews.info/uploads/52b03d248c2ca7ae3fdd1f69ef67ba5c.png
Flushing refers to the temporary or persistent redness of the skin on the face and neck. It occurs due to vasodilation and is known to arise from various causes, such as hormonal changes, sudden temperature fluctuations, inflammatory skin diseases, and prolonged laser treatments.
While laser and hormone therapies are common treatments for flushing, PharmaResearch(CEO Kim Thinkyou, Kang Ki-seok) has recently…
PharmaResearch, "Rejuran Registered " Accelerates Entry into Vietnam
Rejuran Launch Symposium Highlights Latest Aesthetic Trends and DOT Trademark Technology
Image: https://www.getnews.info/uploads/94717ca7a950a52ac08fd7e65857e556.jpg
PharmaResearch (CEO Kim Thinkyou, Kang Ki-seok) announced the official entry into the Vietnamese market through the 'Rejuran Launch Symposium' held on May 17 at the Intercontinental Vietnam.
The symposium was attended by over 400 Vietnamese aesthetic experts and medical professionals who validated the excellence of Rejuran and engaged in in-depth discussions on its application methods.
'Rejuran' is a medical device aimed…
